BioLineRx Ltd. (BLRX)

BioLineRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	7.19	10.44	4.26	10.59	12.99	16.83
Short-Term Investments	20.97	9.13	38.74	40.5	44.15	5.76
Cash & Short-Term Investments	28.16	19.56	42.99	51.08	57.14	22.59
Cash Growth	-29.71%	-54.50%	-15.83%	-10.59%	152.95%	-17.83%
Accounts Receivable	0.08	2.48	0.36	-	-	-
Other Receivables	0.2	1.39	0.35	0.72	0.14	0.14
Receivables	0.28	3.86	0.71	0.72	0.14	0.14
Inventory	2.85	3.15	1.95	-	-	-
Prepaid Expenses	0.57	0.44	1.05	0.2	0.13	0.15
Other Current Assets	-	0.09	0.48	-	-	-
Total Current Assets	31.86	27.1	47.18	52	57.4	22.88
Property, Plant & Equipment	1	1.35	1.89	2.5	2.28	2.7
Other Intangible Assets	10.41	10.45	14.85	21.89	21.7	21.71
Total Assets	43.27	38.91	63.93	76.38	81.39	47.29
Accounts Payable	3.47	5.58	10.87	6.97	5.57	5.92
Accrued Expenses	2.77	3.13	3.27	1.66	1.23	1.44
Current Portion of Long-Term Debt	4.48	4.48	3.15	1.54	2.76	3.09
Current Portion of Leases	0.41	0.52	0.53	0.43	0.17	0.19
Current Unearned Revenue	-	-	12.96	-	-	-
Other Current Liabilities	4.36	1.69	12.02	0.08	0	0
Total Current Liabilities	15.48	15.41	42.78	10.68	9.72	10.64
Long-Term Debt	6.72	8.96	6.63	8.63	-	2.74
Long-Term Leases	1	1.08	1.29	1.73	1.73	1.66
Other Long-Term Liabilities	-	-	-	4.51	1.86	10.22
Total Liabilities	23.2	25.45	50.7	25.54	13.3	25.26
Common Stock	71.82	38.1	31.36	27.1	21.07	9.87
Additional Paid-In Capital	327.48	353.69	355.48	338.98	339.35	279.24
Retained Earnings	-398.64	-399.83	-390.61	-329.99	-305.04	-277.99
Comprehensive Income & Other	19.42	21.5	16.99	14.76	12.72	10.91
Shareholders' Equity	20.07	13.46	13.22	50.84	68.09	22.03
Total Liabilities & Equity	43.27	38.91	63.93	76.38	81.39	47.29
Total Debt	12.6	15.04	11.59	12.32	4.65	7.68
Net Cash (Debt)	15.56	4.52	31.4	38.76	52.48	14.9
Net Cash Growth	76.67%	-85.60%	-18.98%	-26.15%	252.17%	-12.51%
Net Cash Per Share	0.01	0.00	0.03	0.05	0.08	0.06
Filing Date Shares Outstanding	2,558	2,233	1,087	922.96	715.16	349.17
Total Common Shares Outstanding	2,558	1,337	1,087	922.96	715.16	349.17
Working Capital	16.38	11.7	4.4	41.32	47.69	12.24
Book Value Per Share	0.01	0.01	0.01	0.06	0.10	0.06
Tangible Book Value	9.66	3.01	-1.63	28.96	46.38	0.32
Tangible Book Value Per Share	0.00	0.00	-0.00	0.03	0.06	0.00
Machinery	-	2.29	2.93	2.81	2.66	2.56
Leasehold Improvements	-	2.04	2.04	2.04	2.03	2.03

Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q